Regeneron-backed City builds RNAi pipeline with $99.5M series B Secures $99.5 Million in Latest Series B Funding Round

Regeneron-backed City builds RNAi pipeline with $99.5M series B secured $99.5 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.

Regeneron-backed City builds RNAi pipeline with $99.5M series B Raises $99.5 million in Funding

Regeneron-backed City builds RNAi pipeline with $99.5M series B is a Million Series A Financing to Lead the Future of RNAi-based Digital Health company focused on gather data on three RNAi medicines.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Regeneron-backed City builds RNAi pipeline with $99.5M series B operates in Healthcare & Life Sciences. Regeneron-backed City builds RNAi pipeline with $99.5M series B's Series B round shows investors are still backing digital health platforms with real scale narratives. At $100M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

gather data on three RNAi medicines

Looking Ahead

Regeneron-backed City builds RNAi pipeline with $99.5M series B

Source reference: original announcement/article.